Atlas Trials

Materia Medica Holding

43 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Materia Medica Holding

RecordFirmDate
Clinical Trial of the Safety and Tolerability of MMH-522 in Healthy Volunteers (NCT07754279)Materia Medica Holding2026-02-12
Efficacy and Safety of Rengalin in the Treatment of ARVI Cough in Children (NCT07171099)Materia Medica Holding2025-10-03
Clinical Trial of the Safety and Tolerability of the Drug MMH-450 in Healthy Volunteers (NCT07708623)Materia Medica Holding2025-08-15
The Efficacy and Safety of Raphamin in the Treatment of Acute Rhinosinusitis in Adult Patients (NCT06901297)Materia Medica Holding2025-04-03
Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of ARVI in Children Aged 3-12 Years (NCT06715891)Materia Medica Holding2024-11-11
Clinical Trial of the Efficacy and Safety of Raphamin in Combined Treatment of Community-acquired Pneumonia (NCT06263881)Materia Medica Holding2023-12-01
Clinical Trial of the Efficacy and Safety of Raphamin in Prevention of Recurrences of Chronic Bacterial Cystitis (NCT06284265)Materia Medica Holding2023-10-16
Clinical Trial of Efficacy and Safety of Raphamin in the Treatment of Coronavirus Disease 2019 in Outpatients (NCT05364671)Materia Medica Holding2022-04-29
Сlinical Trial of Efficacy and Safety of Prospekta in the Treatment of Post-COVID-19 Asthenia. (NCT05074888)Materia Medica Holding2021-10-15
Efficacy and Safety of Ergoferon for COVID-19 Prevention During Vaccination Against SARS-CoV-2 (NCT05069649)Materia Medica Holding2021-10-06
Clinical Study of Efficacy and Safety of Raphamin in the Treatment of ARVI in Children 12-18 Years Old (NCT04918771)Materia Medica Holding2021-04-29
Prospekta in the Treatment of Cognitive, Behavioral and Psychiatric Disorders in Patients With Vascular Dementia. (NCT04552041)Materia Medica Holding2020-12-03
Clinical Trial of Efficacy and Safety of Prospekta in the Treatment of Attention Deficit/Hyperactivity Disorder in Children (NCT04569357)Materia Medica Holding2020-11-20
Clinical Trial of Efficacy and Safety of MMH-MAP in the Treatment of Cognitive Disorders (NCT04295681)Materia Medica Holding2019-12-12
Clinical Trial of Efficacy and Safety of ММН-407 in the Treatment of Influenza in Outpatient Adults (NCT04250311)Materia Medica Holding2019-12-12
Clinical Trial of Efficacy and Safety of ММН-407 in Acute Respiratory Viral Infection (NCT04244084)Materia Medica Holding2019-10-08
Clinical Trial of Efficacy and Safety of MMH-MAP in the Treatment of Mild Cognitive Impairment in Early Recovery Stage After Ischemic Stroke (NCT03815292)Materia Medica Holding2018-10-19
Clinical Trial of Efficacy and Safety of Subetta in the Treatment of Impaired Glucose Tolerance (NCT03725033)Materia Medica Holding2018-10-10
Clinical Trial of Efficacy and Safety of Anaferon in the Treatment of Acute Respiratory Viral Infections (NCT03707912)Materia Medica Holding2018-10-09
Clinical Trial of Efficacy and Safety of Divaza for Adjustment of Oxidative Disorders in Patients With Cerebral Atherosclerosis (NCT03485495)Materia Medica Holding2018-04-12
Clinical Trial of Anaferon for Children Efficacy in Prevention of Influenza and Other ARVI (NCT03301155)Materia Medica Holding2017-10-03

Track Materia Medica Holding automatically

Every clearance here is in the API, with alerts when new ones post.